Eisai Co. Ltd. v. Roxane Laboratories Inc.

Application Number	Patent Number	External Links
-	US6740669	Espacenet Google Patents
-	US7750028	Espacenet Google Patents

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1645837.) - filed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(els) (Entered: 12/23/2014)

2014-12-23

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 12/23/2014)

2014-12-23

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/14. Date of Expiration of Patent: 11/14/22, 10/19/18.Thirty Month Stay Deadline: 5/14/2017. (els) (Entered: 12/23/2014)

2014-12-23

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2;. (els) (Entered: 12/23/2014)

2014-12-23

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co. Ltd. for Eisai Inc. filed by Eisai Co. Ltd., Eisai Inc.. (els) (Entered: 12/23/2014)

2014-12-23

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Other Affiliate SEAQ International for Novartis Pharma AG filed by Novartis Pharma AG. (els) (Entered: 12/23/2014)

2014-12-23

1

View

Summons Issued with Magistrate Consent Notice attached as to Roxane Laboratories Inc. on 12/23/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (els)

2014-12-23

1

No Actions

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)

2014-12-31

1

No Actions

DECLARATION of Mailing (as to service on Roxane Laboratories, Inc.) by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 01/05/2015)

2015-01-05

1

View

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Roxane Laboratories Inc..(Fineman, Steven) (Entered: 01/20/2015)

2015-01-20

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Fineman, Steven) (Entered: 01/20/2015)

2015-01-20

1

View

ANSWER to 8 Answer to Complaint, Counterclaim by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 02/13/2015)

2015-02-13

1

View

MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch - filed by Roxane Laboratories Inc.. (Lester, Katharine) (Entered: 02/18/2015)

2015-02-18

1

View

SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch filed by Roxane Laboratories Inc. Signed by Judge Leonard P. Stark on 2/19/15. (ntl)

2015-02-19

1

No Actions

Pro Hac Vice Attorney Matthew C. Darch for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-02-19

1

No Actions

Pro Hac Vice Attorney Roger J Chin for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas, )

2015-02-20

1

No Actions

Pro Hac Vice Attorney Jennifer Koh for Roxane Laboratories Inc.,Michelle R. Ma for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-02-24

1

No Actions

NOTICE requesting Clerk to remove Michelle R. Ma as co-counsel. Reason for request: She has left the law firm of Latham & Watkins LLP. (Lester, Katharine) (Entered: 08/03/2015)

2015-08-03

1

View

PROPOSED CONSENT JUDGMENT by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Jacobs, Karen) (Entered: 10/16/2015)

2015-10-16

1

View

CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 10/20/15. (ntl) (Entered: 10/21/2015)

2015-10-21

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669; 7,750,028. (ntl) (Entered: 10/21/2015)

2015-10-21

1

View

Overview

Parties

Defendant

Roxane Laboratories Inc.

Represented By

Plaintiff

Novartis Pharma AG

Represented By

Eisai Inc.

Represented By

Eisai Co. Ltd.

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1645837.) - filed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(els) (Entered: 12/23/2014)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 12/23/2014)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/14. Date of Expiration of Patent: 11/14/22, 10/19/18.Thirty Month Stay Deadline: 5/14/2017. (els) (Entered: 12/23/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2;. (els) (Entered: 12/23/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co. Ltd. for Eisai Inc. filed by Eisai Co. Ltd., Eisai Inc.. (els) (Entered: 12/23/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Other Affiliate SEAQ International for Novartis Pharma AG filed by Novartis Pharma AG. (els) (Entered: 12/23/2014)

Summons Issued with Magistrate Consent Notice attached as to Roxane Laboratories Inc. on 12/23/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (els)

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)

DECLARATION of Mailing (as to service on Roxane Laboratories, Inc.) by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 01/05/2015)

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Roxane Laboratories Inc..(Fineman, Steven) (Entered: 01/20/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Fineman, Steven) (Entered: 01/20/2015)

ANSWER to 8 Answer to Complaint, Counterclaim by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 02/13/2015)

MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch - filed by Roxane Laboratories Inc.. (Lester, Katharine) (Entered: 02/18/2015)

SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch filed by Roxane Laboratories Inc. Signed by Judge Leonard P. Stark on 2/19/15. (ntl)

Pro Hac Vice Attorney Matthew C. Darch for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

Pro Hac Vice Attorney Roger J Chin for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas, )

Pro Hac Vice Attorney Jennifer Koh for Roxane Laboratories Inc.,Michelle R. Ma for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

NOTICE requesting Clerk to remove Michelle R. Ma as co-counsel. Reason for request: She has left the law firm of Latham & Watkins LLP. (Lester, Katharine) (Entered: 08/03/2015)

PROPOSED CONSENT JUDGMENT by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Jacobs, Karen) (Entered: 10/16/2015)

CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 10/20/15. (ntl) (Entered: 10/21/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669; 7,750,028. (ntl) (Entered: 10/21/2015)

Eisai Co. Ltd. v. Roxane Laboratories Inc.

Overview

Parties

Defendant

Roxane Laboratories Inc. Follow

Represented By

Plaintiff

Novartis Pharma AG Follow

Represented By

Eisai Inc. Follow

Represented By

Eisai Co. Ltd. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1645837.) - filed by Eisai Inc., Eisai Co. Ltd., Novartis Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(els) (Entered: 12/23/2014)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 12/23/2014)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/14. Date of Expiration of Patent: 11/14/22, 10/19/18.Thirty Month Stay Deadline: 5/14/2017. (els) (Entered: 12/23/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2;. (els) (Entered: 12/23/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co. Ltd. for Eisai Inc. filed by Eisai Co. Ltd., Eisai Inc.. (els) (Entered: 12/23/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Other Affiliate SEAQ International for Novartis Pharma AG filed by Novartis Pharma AG. (els) (Entered: 12/23/2014)

Summons Issued with Magistrate Consent Notice attached as to Roxane Laboratories Inc. on 12/23/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (els)

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)

DECLARATION of Mailing (as to service on Roxane Laboratories, Inc.) by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 01/05/2015)

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Roxane Laboratories Inc..(Fineman, Steven) (Entered: 01/20/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Fineman, Steven) (Entered: 01/20/2015)

ANSWER to 8 Answer to Complaint, Counterclaim by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG.(Noreika, Maryellen) (Entered: 02/13/2015)

MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch - filed by Roxane Laboratories Inc.. (Lester, Katharine) (Entered: 02/18/2015)

SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin, Jennifer Koh, Emily C. Melvin, Michelle Ma and Matthew C. Darch filed by Roxane Laboratories Inc. Signed by Judge Leonard P. Stark on 2/19/15. (ntl)

Pro Hac Vice Attorney Matthew C. Darch for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

Pro Hac Vice Attorney Roger J Chin for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas, )

Pro Hac Vice Attorney Jennifer Koh for Roxane Laboratories Inc.,Michelle R. Ma for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

NOTICE requesting Clerk to remove Michelle R. Ma as co-counsel. Reason for request: She has left the law firm of Latham & Watkins LLP. (Lester, Katharine) (Entered: 08/03/2015)

PROPOSED CONSENT JUDGMENT by Eisai Co. Ltd., Eisai Inc., Novartis Pharma AG. (Jacobs, Karen) (Entered: 10/16/2015)

CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 10/20/15. (ntl) (Entered: 10/21/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669; 7,750,028. (ntl) (Entered: 10/21/2015)

Track Case Updates

Roxane Laboratories Inc.

Novartis Pharma AG

Eisai Inc.

Eisai Co. Ltd.